Charlotte's Web Holdings (CWBHF) Amortization of Deferred Charges (2021 - 2026)

Charlotte's Web Holdings' (CWBHF) quarterly Amortization of Deferred Charges came in at $114000.0 in Q1 2026, down 75.9% year-on-year from $473000.0 in Q1 2025, and down 50.65% on a QoQ basis from $231000.0 in Q4 2025.

Charlotte's Web Holdings (CWBHF) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Charlotte's Web Holdings (CWBHF) has 6 years of Amortization of Deferred Charges data on file, last reported at $114000.0 in Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 75.9% year-over-year to $114000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 32.26% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 10.84% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $114000.0, down from $231000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for CWBHF reached as high as $641000.0 in Q3 2022 and fell as low as $114000.0 in Q1 2026.
  • Historically, Amortization of Deferred Charges has averaged $442823.5 across 5 years, with a median of $465000.0 in 2023.
  • On a YoY basis, Amortization of Deferred Charges climbed as much as 148.97% in 2022 and fell as far as 88.64% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $269000.0 in 2022, then soared by 72.86% to $465000.0 in 2023, then decreased by 14.41% to $398000.0 in 2024, then slumped by 41.96% to $231000.0 in 2025, then slumped by 50.65% to $114000.0 in 2026.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $114000.0 in Q1 2026, $231000.0 in Q4 2025, and $398000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Charlotte's Web Holdings 41.51 Mn 36.32 Mn 5.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 114,000.00
Mar 31, 2026 114,000.00
Dec 31, 2025 231,000.00
Dec 31, 2025 231,000.00
Sep 30, 2025 398,000.00
Sep 30, 2025 398,000.00
Jun 30, 2025 477,000.00
Jun 30, 2025 477,000.00
Mar 31, 2025 473,000.00
Mar 31, 2025 473,000.00
Dec 31, 2024 398,000.00
Dec 31, 2024 398,000.00
Sep 30, 2024 465,000.00
Sep 30, 2024 465,000.00
Jun 30, 2024 465,000.00
Jun 30, 2024 465,000.00
Mar 31, 2024 443,000.00
Mar 31, 2024 443,000.00
Dec 31, 2023 465,000.00
Dec 31, 2023 465,000.00